Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1709626 · FYE Dec 31 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $1.21Day −6.20%1Y −87.9%Off 52W high −88.6%Vol (1Y) 103.2%
Daily closing price, split-adjusted to the current basis; 3y shown of 2,076 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest0.0% of sh out |
| Days to cover1.9d |
| 13F net flow (QoQ)−0.00% |
| Top-10 13F concentration100.0% |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Earnings (TTM)-£29.4M |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (GBP). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−66.4% |
| 1Y−87.9% |
| 3Y−100.0% |
| 5Y−100.0% |
| Since incept. (ann.)−71.6% |
Price return through 2026-07-29 · series begins 2017-09-28. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)103.2% |
| Ann. volatility (3Y)217.8% |
| Sharpe (1Y)−1.67 |
| Sharpe (3Y)−0.37 |
| Max drawdown (1Y)−89.0% |
| Max drawdown (3Y)−100.0% |
| Beta (3Y vs SPY)1.88 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| Glass Jacobson Investment Advisors llc | 15,000 | $21,000 | 0.00% | +0.0% |
| CITADEL ADVISORS LLC | 13,855 | $19,536 | 0.00% | new |
| Virtu Financial LLC | 13,433 | $19,000 | 0.00% | new |
| JANE STREET GROUP, LLC | 10,511 | $14,715 | 0.00% | −7.2% |
| RHUMBLINE ADVISERS | 3,722 | $5,245 | 0.00% | −24.2% |
| MORGAN STANLEY | 2 | $3 | 0.00% | −98.1% |
| Caitong International Asset Management Co., Ltd | 2 | $3 | 0.00% | new |
| ACADIAN ASSET MANAGEMENT LLC | 2 | $0 | 0.00% | +0.0% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
No reported quarters on file for NCNA.
